AllAnalyst Report
Morningstar•July 29, 2022
Morningstar•July 29, 2022Bio-Rad Laboratories, Inc.: Tough Comparables and Foreign Exchange Lead to Bio-Rad Sales Decline; Core Results Meet Expectations
Summary
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeActions
Download Full ReportRelated Reports
- Analyst Report: Merck & Co., Inc.Apr 25, 2024 •
MRK
- Analyst Report: Laboratory Corporation of America HoldingsApr 25, 2024 •
LH
- Analyst Report: IDEX CorporationApr 24, 2024 •
IEX
- Analyst Report: Thermo Fisher Scientific Inc.Apr 24, 2024 •
TMO
- Market Digest: BX, GE, GPC, NUE, SAP, RTX, BMI, MSCI, CFGApr 24, 2024 •
SAP, CFG, BX, RTX, MSCI, GPC, GE, BMI, NUE
Analyst Profile
Aaron Degagne
Equity AnalystAaron DeGagne is an equity analyst, financial services, for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. He contributes primarily to the research coverage of South American banks and Canadian insurance companies and conducts general research on the global financial-services sector.Before joining Morningstar in 2017, DeGagne was an accounting intern for Campgroup and completed two lending-group internships with RBC Capital Markets.DeGagne holds a Bachelor of Business Administration in finance from the University of Notre Dame’s Mendoza College of Business.